HAVLX
Price
$20.19
Change
+$0.15 (+0.75%)
Updated
Apr 17 closing price
Net Assets
1.27B
VFIAX
Price
$487.66
Change
+$0.66 (+0.14%)
Updated
Apr 17 closing price
Net Assets
1.32T
Ad is loading...

HAVLX vs VFIAX

Header iconHAVLX vs VFIAX Comparison
Open Charts HAVLX vs VFIAXBanner chart's image
Harbor Large Cap Value Instl
Price$20.19
Change+$0.15 (+0.75%)
VolumeN/A
Net Assets1.27B
Vanguard 500 Index Admiral
Price$487.66
Change+$0.66 (+0.14%)
VolumeN/A
Net Assets1.32T
HAVLX vs VFIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HAVLX vs. VFIAX commentary
Apr 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HAVLX is a Buy and VFIAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VFIAX has more cash in the bank: 1.32T vs. HAVLX (1.27B). VFIAX (1.35) and HAVLX (1.31) have matching dividends . HAVLX was incepted earlier than VFIAX: HAVLX (37 years) vs VFIAX (24 years). HAVLX (0.73) is less costly to investors than VFIAX (0.04). HAVLX is a more actively managed with annual turnover of: 11.00 vs. VFIAX (2.00). VFIAX has a lower initial minimum investment than HAVLX: VFIAX (3000) vs HAVLX (50000). VFIAX annual gain was more profitable for investors over the last year : 5.24 vs. HAVLX (-6.27). VFIAX return over 5 years is better than : 83.83 vs. HAVLX (44.76).
HAVLXVFIAXHAVLX / VFIAX
Total Expense Ratio0.690.041,725%
Annual Report Gross Expense Ratio0.730.041,825%
Fund Existence37 years24 years-
Gain YTD-5.570-10.13955%
Front LoadN/AN/A-
Min. Initial Investment5000030001,667%
Min. Initial Investment IRAN/AN/A-
Net Assets1.27B1.32T0%
Annual Yield % from dividends1.311.3597%
Returns for 1 year-6.275.24-120%
Returns for 3 years-1.9220.37-9%
Returns for 5 years44.7683.8353%
Returns for 10 years73.85151.9349%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PPBT2.840.33
+13.15%
Purple Biotech Ltd
IMNM7.910.74
+10.32%
Immunome
EDU44.820.63
+1.43%
New Oriental Education and Technology Group
PTGX46.280.48
+1.05%
Protagonist Therapeutics
PBYI2.86-0.02
-0.69%
Puma Biotechnology